Amid reports over potential rare side effects of the AstraZeneca-Oxford COVID-19 vaccine, Bharat Biotech, which developed the Covaxin, said in a statement that the vaccine was developed with a "single-minded focus on safety first."
Brussels [Belgium], November 11 (ANI/Sputnik): The EU drug regulator advised on Thursday listing blood clots in the brain as a rare side effect of AstraZeneca's COVID-19 after observing cases that were not linked to a low platelet count.
London [UK], November 8 (ANI/Xinhua): Another 30,305 people in Britain have tested positive for COVID-19, bringing the total number of coronavirus cases in the country to 9,301,909, according to official figures released Sunday.
London [UK], October 30 (ANI/Sputnik): The United Kingdom on Saturday announced that it would donate 20 million more Oxford/AstraZeneca vaccine doses by the end of the year to countries in need.
Moscow [Russia], October 11 (ANI): Sputnik V team on Monday refuted the UK media reports that claimed Russia's COVID-19 vaccine was allegedly based on research from the Oxford/AstraZeneca vaccine and called it "another 'fake news and blatant lie' based on anonymous sources".
New Delhi [India] September 21 (ANI): India will take reciprocal measures against UK's "discriminatory" move to recognise AstraZeneca Covid-19 vaccine but not Covishield, said Foreign Secretary Harsh Vardhan Shringla on Tuesday.
Canberra [Australia], September 6 (ANI/Xinhua): Australia has reported more than 1,000 new coronavirus cases for the 10th consecutive day as the country continued to battle the third wave of COVID-19 infections.
Khartoum [Sudan], August 10 (ANI): China has provided numerous interest-free loans and grants to the Sudanese government for diverse projects, but the country has now begun to sense the exploitation being meted out to them by the Chinese.
Berlin [Germany] August 5 (ANI/FENA): The German government has announced that it will donate all future orders for the AstraZeneca vaccine to the COVAX initiative with the support of the United Nations.
New Delhi [India], July 17 (ANI): Chief Executive Officer (CEO) and owner of the Serum Institute of India (SII) on Saturday said that it was good news for international travellers that Covishield, the Indian version of the Oxford-Astrazeneca vaccine was now recognised and accepted by 16 E
New Delhi [India], July 9 (ANI): Belgium has recognised the Covishield vaccine produced by the Serum Institute of India (SII) and developed by AstraZeneca and Oxford University, said the Embassy of Belgium in India on Friday.